Read E.V.I.dently Today for current news about health policy and events, among other topics.
E.V.I.dently Today Blog
The Food and Drug Administration (FDA) this week has released a series of draft guidance documents that clarify how and when different types of clinical and economic information may be communicated.
In the December issue of Employee Benefit News, NPC Vice President of Comparative Effectiveness Research Jennifer Graff, PharmD, outlines a framework for the consideration of treatment flexibility in benefit design.
As our health care system shifts from a focus on volume to value, a key question emerges: Who gets to define value? National Pharmaceutical Council (NPC) President Dan Leonard and other health stakeholders explored that question yesterday during a panel discussion on “Replacing Value Frameworks with Patient-Driven Value” at a conference hosted by BioNJ.
How do we measure the value of a health care treatment?